CF
GNOM icon

Centaurus Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Centaurus Financial’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
4,186
+135
+3% +$6.44K 0.01% 828
2026
Q1 		$177K Buy
4,051
+26
+0.6% +$1.2K 0.01% 859
2025
Q4 		$183K Sell
4,025
-202
-5% -$8.95K 0.01% 836
2025
Q3 		$164K Buy
4,227
+490
+13% +$17.7K 0.01% 863
2025
Q2 		$126K Sell
3,737
-237
-6% -$7.5K 0.01% 875
2025
Q1 		$126K Buy
3,974
+25
+0.6% +$949 0.01% 819
2024
Q4 		$153K Buy
3,949
+200
+5% +$8.4K 0.01% 748
2024
Q3 		$169K Buy
3,749
+246
+7% +$11K 0.01% 680
2024
Q2 		$146K Buy
+3,503
New +$146K 0.01% 684
2024
Q1 		– Sell
-3,185
Closed -$147K – 800
2023
Q4 		$147K Buy
3,185
+406
+15% +$16.6K 0.01% 660
2023
Q3 		$113K Buy
2,779
+118
+4% +$5.37K 0.01% 695
2023
Q2 		$129K Buy
2,661
+22
+0.8% +$1.1K 0.01% 675
2023
Q1 		$130K Buy
2,639
+489
+23% +$25.2K 0.01% 776
2022
Q4 		$109K Buy
+2,150
New +$111K 0.01% 766
2022
Q2 		– Sell
-1,749
Closed -$105K – 862
2022
Q1 		$105K Buy
1,749
+31
+2% +$1.96K 0.01% 855
2021
Q4 		$136K Buy
1,718
+436
+34% +$36.6K 0.01% 794
2021
Q3 		$114K Buy
+1,282
New +$120K 0.01% 825

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Centaurus Financial's GNOM Position: Q2 2026 in Review

Centaurus Financial increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 3.3% in Q2 2026, buying an estimated $6.44K and bringing the position to 4,186 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #828.

Centaurus Financial first reported a position in GNOM in Q3 2021 and has held it in 17 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Centaurus Financial held 4,186 shares of Global X Genomics & Biotechnology ETF worth $238K as of Q2 2026.
  • Centaurus Financial bought 135 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $6.44K.
  • Global X Genomics & Biotechnology ETF made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #828 holding.
  • Centaurus Financial first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and has held it in 17 quarters since.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.